These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6718438)

  • 1. [Kinetics of release from suppositories formulated with phenobarbital acid or sodium, and semi-synthetic glyceride (Witepsol H 15). I. Freshly prepared suppositories].
    Lasserre Y; Peneva B; Jacob M; Puech A
    Pharm Acta Helv; 1984; 59(3):77-9. PubMed ID: 6718438
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetics of liberation from suppository bases of phenobarbital acid and sodium and a semi-synthetic glyceride (Witepsol H 15). II. Suppositories after storage].
    Lasserre Y; Peneva MB; Jacob M; Puech A; Sabatier R
    Pharm Acta Helv; 1987; 62(10-11):287-91. PubMed ID: 3438314
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on aminophenazone and phenobarbital release from suppositories prepared on different bases.
    Piasecka H; Zakrzewski Z
    Pol J Pharmacol Pharm; 1976; 28(2):199-203. PubMed ID: 934948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rectal absorption of phenobarbital in children as affected by different vehicles].
    Heimann G; Neuwald F; Gladtke E
    Arzneimittelforschung; 1978; 28(6):1023-6. PubMed ID: 581999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release and rectal absorption of aminophylline suppositories prepared in a hospital pharmacy.
    Fujii T; Kubota A; Mizushima N
    Tokai J Exp Clin Med; 1982 Sep; 7(5):539-46. PubMed ID: 7182946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of pyrazolone derivatives from suppositories formulated with hydrophilic and hydrophobic bases.
    Bećirević M; Petricić V
    Pharmazie; 1986 May; 41(5):338-40. PubMed ID: 3737665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.
    Ozyazici M; Turgut EH; Taner MS; Köseoglu K; Ertan G
    J Drug Target; 2003 Apr; 11(3):177-85. PubMed ID: 14577974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release property of progesterone from a mixed-base suppository consisting of Witepsol W35 and Witepsol E85.
    Iwata M; Komiya S; Nakamura K; Kiuchi M; Andoh N; Hirahara F; Maitani Y; Takayama K
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1039-45. PubMed ID: 11794806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of different bile salts on the relative hypoglycemia of witepsol W35 suppositories containing insulin in diabetic Beagle dogs.
    Hosny EA; Al-Shora HI; Elmazar MM
    Drug Dev Ind Pharm; 2001 Sep; 27(8):837-45. PubMed ID: 11699836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in vitro release of suppositories containing dry extract of Ruscus aculeatus L.
    Peneva B; Krasteva I; Nikolov S; Minkov E
    Pharmazie; 2000 Dec; 55(12):956. PubMed ID: 11189878
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioavailability of phenobarbital by rectal administration.
    Matsukura M; Higashi A; Ikeda T; Matsuda I
    Pediatr Pharmacol (New York); 1981; 1(3):259-65. PubMed ID: 7346746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correction of the fusion point of suppositories with semi-synthetic excipients].
    Van Bosch F; Delrez M; De Nève R
    Pharm Acta Helv; 1976; 51(4):106-12. PubMed ID: 967902
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
    Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
    Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The bioavailability of trapidil from suppositories (author's transl)].
    Bornschein M; Grohmann A; Hackenberger F; Grune D
    Pharmazie; 1981 Dec; 36(12):830-2. PubMed ID: 7330086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
    Pasich J; Drobnicka B; Kasprzyk A
    Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of matrix and two layered sustained release suppositories of theophylline.
    Maity S; Sa B; Bandyopadhyay AK
    Boll Chim Farm; 2001; 140(6):462-6. PubMed ID: 11822240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro properties of ciprofloxacin suppositories formulated with glycerogelatin and theobroma oil bases.
    Ofoefule SI; Nwankwo C; Chukwu A; Orisakwe OE
    Boll Chim Farm; 1998 Oct; 137(9):341-4. PubMed ID: 9859595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of the Ph.Eur. flow-through cell for dissolution testing of the compounded rectal suppositories containing indomethacin or sodium diclofenac.
    Woyczikowski B; Szulc J; Sznitowska M; Janicki S; Pilichowski J; Urbańska A
    Acta Pol Pharm; 2003; 60(3):169-72. PubMed ID: 14556483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Semi-synthetic glycerides. Excipients for suppositories].
    Ceschel G; Desantis A
    Boll Chim Farm; 1969 Sep; 108(9):524-6. PubMed ID: 5364380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.